NettetEddie Kim is a Senior Corporate Paralegal at ACELYRIN based in Woodland Hills, California. Previously, Eddie was an Associate Director, Corporate Paralegal at … NettetJonathan Kim Director, Global Trade Compliance and Policy Chair, Asian American and Pacific Islander (AAPI) ERG Raleigh-Durham-Chapel Hill Area Wolfspeed Jonathan …
ACELYRIN, INC. Adds Two Veteran C-suite Leaders - Yahoo Finance
Nettet7. apr. 2024 · The Company's lead technologies are for the healing and restoration of bone and other tissues. Its lead products are based on recombinant human platelet-derived growth factor BB (rhPDGF-BB). In March 2013, BioMimetic Therapeutics was acquired by Wright Medical Group. The valuation of BioMimetic Therapeutics was $190 million. NettetACELYRIN is building a biopharma company with a corporate culture of Courageous Caring - placing patients first and embracing the concept that all of us together are … the school choir
100+ "Jonathan Kim" profiles LinkedIn
NettetACELYRIN is a biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies. Los Angeles, California, … Nettet14. nov. 2024 · Kim is joining Woodland Hills, California-based Acelyrin from synthetic biotechnology company Zymergen, where she was chief legal officer and head of corporate development. The company was sold to ... Nettet14. sep. 2024 · Acelyrin sets hopes high for arthritis drug with $300M fundraise. The well-funded startup is planning Phase 3 trials for a drug it claims could be superior to IL-17 inhibitors from Novartis and others. Acelyrin, a Californian biotechnology startup, has raised a $300 million Series C round that’ll be used to support late-stage clinical testing ... trailer ball size chart